Multimmune Gmbh News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 04, 2021 11:35 ET | Source: Alphageneron Pharmaceuticals Alphageneron Pharmaceuticals Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1 st, 2020, for its clinical stage autologous Natural Killer (“NK”) cel...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ... Alphageneron PharmaceuticalsFebruary 4, 2021 GMT CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Killer (“NK”) cell therapy and companion diagnostic platform, for all fields worldwide. The autolo...